BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/7/2025 6:39:58 AM | Browse: 143 | Download: 432
 |
Received |
|
2025-05-26 12:40 |
|
Peer-Review Started |
|
2025-05-26 12:40 |
|
First Decision by Editorial Office Director |
|
2025-05-29 23:58 |
|
Return for Revision |
|
2025-05-29 23:58 |
|
Revised |
|
2025-06-04 07:16 |
|
Publication Fee Transferred |
|
2025-06-06 07:41 |
|
Second Decision by Editor |
|
2025-07-17 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-07-17 05:07 |
|
Articles in Press |
|
2025-07-17 05:07 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-08-04 01:42 |
|
Publish the Manuscript Online |
|
2025-08-07 06:39 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Association of triglyceride-glucose index with long-term prognosis in advanced hepatocellular carcinoma patients receiving immunotherapy and targeted therapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Geng-Chen Li, Zhi-Yuan Yao, Hong-Sen Mao and Zheng-Xiang Han |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Zheng-Xiang Han, PhD, Professor, Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, No. 99 Huaihai West Road, Xuzhou 221000, Jiangsu Province, China. xzpxlgc@163.com |
| Key Words |
Hepatocellular carcinoma; Triglyceride-glucose index; Camrelizumab; Lenvatinib; Efficacy; Safety |
| Core Tip |
Primary liver cancer ranks among the most prevalent and lethal malignancies worldwide. Although combination therapies have improved treatment options, overall prognosis remains unsatisfactory. The triglyceride-glucose index, a simple surrogate marker of insulin resistance, has recently been associated with tumor progression and immune modulation. This retrospective study evaluates the prognostic significance of the triglyceride-glucose index in patients with advanced hepatocellular carcinoma receiving immunotherapy combined with targeted therapy, offering insights into its potential role in risk stratification and clinical decision-making. |
| Publish Date |
2025-08-07 06:39 |
| Citation |
Li GC, Yao ZY, Mao HS, Han ZX. Association of triglyceride-glucose index with long-term prognosis in advanced hepatocellular carcinoma patients receiving immunotherapy and targeted therapy. World J Gastroenterol 2025; 31(30): 109863 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i30/109863.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i30.109863 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
